Lv6
1650 积分 2023-02-19 加入
Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small-cell lung cancer: NCT01631357
17天前
已完结
A Phase IB Trial of Autologous Cytokine‐Induced Killer Cells in Combination with Sintilimab, Monoclonal Antibody Against Programmed Cell Death‐1, plus Chemotherapy in Patients with Advanced Non‐Small‐Cell Lung Cancer
17天前
已完结
Memory-like natural killer cells for cancer immunotherapy
7个月前
已完结
Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
7个月前
已完结
PP086 A phase IIa study of autologous natural killer cells with hepatic arterial infusion chemotherapy in patients with locally advanced hepatocellular carcinoma: Final report
7个月前
已关闭
The safety and feasibility of multiple intrathecal injections of allogenic NK cells in pediatrics with refractory/recurrent brain tumors
7个月前
已完结
NK cells adjuvant therapy shows survival benefits in a gastric mixed signet ring cell carcinoma patient
7个月前
已完结
P-344 Celecoxib combined with weekly irinotecan (CPT-11) and docetaxel for the treatment of patients with advanced non-small cell lung cancer (NSCLC)
7个月前
已完结
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
7个月前
已完结
Late-Stage Ovarian Cancer With Systemic Multiple Metastases Marked Shrinkage Using a Combination of Wilms' Tumor Antigen 1 (WT1) Dendritic Cell Vaccine, Natural Killer (NK) Cell Therapy, and Nivolumab
7个月前
已完结
皖公网安备34019202002308
